CytomX Therapeutics Inc. | Key People and Executives
Sean A. McCarthy
President, Chief Executive Officer & Director
Charles S. Fuchs
Independent Director
John A. Scarlett
Independent Director
Matthew P. Young
Independent Director
Fred W. Gluck
Independent Director
Sean A. McCarthy
President, Chief Executive Officer & Director
Debanjan Ray
CFO & Principal Accounting Officer
William Michael Kavanaugh
CSO, Head-Research & Non-Clinical Development
Rachel W. Humphrey
Chief Medical Officer
Danielle Olander
Senior VP-Talent & Administrative Operations
Sridhar Viswanathan
VP-Process Sciences & Manufacturing Operations
Christopher S. Keenan
Vice President-IR & Corporate Communications
Lloyd A. Rowland
Senior Vice President & General Counsel
Charles S. Fuchs
Independent Director
John A. Scarlett
Independent Director
Matthew P. Young
Independent Director
Frederick W. Gluck
Independent Director
| Address |
151 Oyster Point Boulevard
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.cytomx.com |
| Updated |
07/08/2019 |
| CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. The company was founded by Frederick W. |
